SMALL
DOGS
ROCK!
Features Functions Benefits
Subcutaneous and
intravenous administration
of METACAM (meloxicam)
Solution for Injection
An initial injection at your
clinic can provide a rapid
and visible onset of pain
relief via subcutaneous or
intravenous administration
Shows owners the benefits
firsthand, which helps
increase compliance
Liquid formulation of
METACAM (meloxicam
oral suspension)
Can be dosed in 1-lb
and 5-lb increments
Allows for precise dosing
for any-sized dog
Titration of METACAM
(meloxicam oral suspension)
to lowest effective dose
Follows the
recommendations set
forth by the FDA
1
Extends the duration of the
bottle to increase convenience
and decrease cost
METACAM CELEBRATES
METACAM helps you administer just the right dose
for each dog's individual needs.
METACAM keeps them moving by
managing canine osteoarthritis pain
with precision dosing that's just
right for them. (And, of course,
it's perfect for big dogs, too.)
(meloxica m )
IMPORTANT SAFETY INFORMATION for METACAM (meloxicam oral suspension) and
METACAM (meloxicam) Solution for Injection: METACAM (meloxicam oral suspension)
is for use in dogs only. Repeated use of meloxicam in cats has been associated with acute
renal failure and death. Do not administer additional injectable or oral meloxicam to cats.
As a class, cyclo- oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or
liver side effects. The most common side effects reported in field studies were vomiting and soft
stool/ diarrhea. These are usually mild, but may be serious. If side effects occur, dog owners should
halt therapy and contact their veterinarian. Dogs should be evaluated for pre-existing conditions and
currently prescribed medications prior to treatment with METACAM, then monitored regularly while
on therapy. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should
be avoided or monitored closely. Please refer to the package insert for complete product information
or visit www. metacam. com. Please see Brief Summary on page 34.